1
|
Fardella E, Zanirato G, Magni M, Caldarelli N, Chiappella A, Dodero A, Ljevar S, Orsucci L, Re A, Usai SV, Stefoni V, Castellino C, Rossi FG, Pinto A, Carniti C, Corradini P. Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas. Br J Haematol 2024; 204:1752-1756. [PMID: 38176400 DOI: 10.1111/bjh.19280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2023] [Revised: 12/14/2023] [Accepted: 12/19/2023] [Indexed: 01/06/2024]
Abstract
Peripheral T-cell lymphomas (PTCLs) have a poor prognosis and, to date, there are no reliable predictive biomarkers of response. In this work we explored the prognostic impact of cell-free DNA (cfDNA) concentration in 75 newly diagnosed patients enrolled in a prospective multicenter study. Pre-treatment cfDNA was strongly associated with clinical risk factors and was identified as a superior predictor for shorter progression-free survival in multivariable analysis, outweighing canonical risk parameters. Furthermore, we identified a cfDNA value above which survival worsens. In conclusion, pre-treatment cfDNA concentration represents an easily usable predictive biomarker that is highly associated with survival of PTCL patients.
Collapse
MESH Headings
- Humans
- Lymphoma, T-Cell, Peripheral/mortality
- Lymphoma, T-Cell, Peripheral/diagnosis
- Lymphoma, T-Cell, Peripheral/blood
- Lymphoma, T-Cell, Peripheral/genetics
- Male
- Female
- Middle Aged
- Aged
- Cell-Free Nucleic Acids/blood
- Prognosis
- Adult
- Biomarkers, Tumor/blood
- Prospective Studies
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Collapse
Affiliation(s)
| | - G Zanirato
- Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - M Magni
- Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | | | - A Chiappella
- Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - A Dodero
- Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - S Ljevar
- Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | - L Orsucci
- Division of Hematology, Azienda Ospedaliera e Universitaria Città della Salute e della Scienza, Turin, Italy
| | - A Re
- Hematology Division, ASST Spedali Civili di Brescia, Brescia, Italy
| | - S V Usai
- Hematology Unit, Ospedale Oncologico Armando Businco, Cagliari, Italy
| | - V Stefoni
- Institute of Hematology Seràgnoli, University of Bologna, Bologna, Italy
| | - C Castellino
- Division of Hematology, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
| | - F G Rossi
- Division of Hematology, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy
| | - A Pinto
- Hematology-Oncology & Stem Cell Transplantation Unit, IRCCS Istituto Nazionale Tumori, Fondazione G. Pascale, Napoli, Italy
| | - C Carniti
- Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - P Corradini
- University of Milan, Milan, Italy
- Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| |
Collapse
|
2
|
Abstract
Summary Background. Kounis syndrome (KS) is defined as a rare cause of an acute coronary syndrome associated with systemic allergic reactions. To establish the prevalence of KS among the patients with diagnosis of anaphylaxis, we described clinical features, cardiological and allergological outcomes of patients evaluated in our allergy outpatient clinic. Methods. A retrospective study was carried out in the Allergy Unit of Novara hospital, from January 2008 to March 2020. Skin tests and in vitro tests were performed with suspected etiological agents. Results. We found 9 adults with KS (2%) out of 444 subjects who had experienced anaphylactic reactions (4/9 to Hymenoptera stings, 5/9 to drugs). Conclusions. The present study highlights the importance of suspicion of KS that appears not so uncommon in patients with anaphylaxis. KS seems to be a rare disease because unrecognized in diagnosis of anaphylaxis.
Collapse
Affiliation(s)
- G Zisa
- Allergy Unit, Department of Internal Medicine, Hospital Maggiore della Carità, Novara, Italy
| | - A Panero
- Department of Medicine, Hospital of Biella, Biella, Italy
| | - A Re
- Department of Medicine, Hospital Maggiore della Carità, Novara, Italy
| | - M G Mennuni
- Division of Cardiology, Hospital Maggiore della Carità, Novara, Italy
| | - G Patti
- Division of Cardiology, Hospital Maggiore della Carità, Novara, Italy
- Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
| | - M Pirisi
- Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
- Division of Internal Medicine, Hospital Maggiore della Carità, Novara, Italy
| |
Collapse
|
3
|
Antonicelli G, Ricci L, Tarraran L, Fraterrigo Garofalo S, Re A, Vasile NS, Verga F, Pirri CF, Menin B, Agostino V. Expanding the product portfolio of carbon dioxide and hydrogen-based gas fermentation with an evolved strain of Clostridium carboxidivorans. Bioresour Technol 2023; 387:129689. [PMID: 37597573 DOI: 10.1016/j.biortech.2023.129689] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 08/09/2023] [Accepted: 08/15/2023] [Indexed: 08/21/2023]
Abstract
CO2:H2-based gas fermentation with acetogenic Clostridium species are at an early stage of development. This work exploited the Adaptive Laboratory Evolution technique to improve the growth of C. carboxidivorans P7 on CO2 and H2. An adapted strain with decreased growth lag phase and improved biomass production was obtained. Genomic analysis revealed a conserved frameshift mutation in the catalytic subunit of the hexameric hydrogenase gene. The resulted truncated protein variant, most likely lacking its functionality, suggests that other hydrogenases might be more efficient for H2-based growth of this strain. Furthermore, the adapted strain generated hexanol as primary fermentation product. For the first time, hexanol was produced directly from CO2:H2 blend, achieving the highest maximum productivity reported so far via gas fermentation. Traces of valerate, pentanol, eptanol and octanol were observed in the fermentation broth. The adapted strain shows promising to enrich the product spectrum targetable by future gas fermentation processes.
Collapse
Affiliation(s)
- G Antonicelli
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy; Department of Environment, Land and Infrastructure Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - L Ricci
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy
| | - L Tarraran
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy; Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - S Fraterrigo Garofalo
- Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - A Re
- Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - N S Vasile
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy; Department of Environment, Land and Infrastructure Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - F Verga
- Department of Environment, Land and Infrastructure Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - C F Pirri
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy; Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - B Menin
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy; Istituto di Biologia e Biotecnologia Agraria, Consiglio Nazionale delle Ricerche, Via Alfonso Corti 12, 20133 Milan, Italy
| | - V Agostino
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy.
| |
Collapse
|
4
|
Mongelli A, Panunzi S, Nesta M, Gottardi Zamperla M, Atlante S, Barbi V, Mongiardini V, Ferraro F, De Martino S, Cis L, Re A, Maltese S, Bachetti T, La Rovere MT, Martelli F, Pesce M, Nanni S, Massetti M, Pontecorvi A, Farsetti A, Gaetano C. Distinguishable DNA methylation defines a cardiac-specific epigenetic clock. Clin Epigenetics 2023; 15:53. [PMID: 36991505 PMCID: PMC10053964 DOI: 10.1186/s13148-023-01467-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2022] [Accepted: 03/18/2023] [Indexed: 03/31/2023] Open
Abstract
BACKGROUND The present study investigates whether epigenetic differences emerge in the heart of patients undergoing cardiac surgery for an aortic valvular replacement (AVR) or coronary artery bypass graft (CABG). An algorithm is also established to determine how the pathophysiological condition might influence the human biological cardiac age. RESULTS Blood samples and cardiac auricles were collected from patients who underwent cardiac procedures: 94 AVR and 289 CABG. The CpGs from three independent blood-derived biological clocks were selected to design a new blood- and the first cardiac-specific clocks. Specifically, 31 CpGs from six age-related genes, ELOVL2, EDARADD, ITGA2B, ASPA, PDE4C, and FHL2, were used to construct the tissue-tailored clocks. The best-fitting variables were combined to define new cardiac- and blood-tailored clocks validated through neural network analysis and elastic regression. In addition, telomere length (TL) was measured by qPCR. These new methods revealed a similarity between chronological and biological age in the blood and heart; the average TL was significantly higher in the heart than in the blood. In addition, the cardiac clock discriminated well between AVR and CABG and was sensitive to cardiovascular risk factors such as obesity and smoking. Moreover, the cardiac-specific clock identified an AVR patient's subgroup whose accelerated bioage correlated with the altered ventricular parameters, including left ventricular diastolic and systolic volume. CONCLUSION This study reports on applying a method to evaluate the cardiac biological age revealing epigenetic features that separate subgroups of AVR and CABG.
Collapse
Affiliation(s)
- A Mongelli
- Laboratorio di Epigenetica, Istituti Clinici Scientifici (ICS) Maugeri IRCCS, 27100, Pavia, Italy
- Center for Translational and Experimental Cardiology (CTEC), University of Zurich, 8952, Schlieren, Switzerland
| | - S Panunzi
- National Research Council (CNR)-IASI, 00185, Rome, Italy
| | - M Nesta
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
| | - M Gottardi Zamperla
- Laboratorio di Epigenetica, Istituti Clinici Scientifici (ICS) Maugeri IRCCS, 27100, Pavia, Italy
| | - S Atlante
- Laboratorio di Epigenetica, Istituti Clinici Scientifici (ICS) Maugeri IRCCS, 27100, Pavia, Italy
| | - V Barbi
- Laboratorio di Epigenetica, Istituti Clinici Scientifici (ICS) Maugeri IRCCS, 27100, Pavia, Italy
| | - V Mongiardini
- Laboratorio di Epigenetica, Istituti Clinici Scientifici (ICS) Maugeri IRCCS, 27100, Pavia, Italy
- Molecular Medicine, Istituto Italiano di Tecnologia, Genoa, Italy
| | - F Ferraro
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - S De Martino
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - L Cis
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - A Re
- National Research Council (CNR)-IASI, 00185, Rome, Italy
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - S Maltese
- National Research Council (CNR)-IRIB, 90146, Palermo, Italy
| | - T Bachetti
- Direzione Scientifica Centrale ICS Maugeri IRCCS, Pavia, Italy
| | - M T La Rovere
- Dipartimento di Cardiologia ICS Maugeri and Direzione Scientifica ICS Maugeri Montescano IRCCS, Pavia, Italy
| | - F Martelli
- Molecular Cardiology Laboratory, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy
| | - M Pesce
- Unità di Ingegneria Tissutale Cardiovascolare, Centro Cardiologico Monzino IRCCS, 20138, Milan, Italy
| | - S Nanni
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - M Massetti
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - A Pontecorvi
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - A Farsetti
- National Research Council (CNR)-IASI, 00185, Rome, Italy.
| | - C Gaetano
- Laboratorio di Epigenetica, Istituti Clinici Scientifici (ICS) Maugeri IRCCS, 27100, Pavia, Italy.
| |
Collapse
|
5
|
Appel S, Bagdasarian Z, Basilico D, Bellini G, Benziger J, Biondi R, Caccianiga B, Calaprice F, Caminata A, Cavalcante P, Chepurnov A, D'Angelo D, Derbin A, Di Giacinto A, Di Marcello V, Ding XF, Di Ludovico A, Di Noto L, Drachnev I, Franco D, Galbiati C, Ghiano C, Giammarchi M, Goretti A, Göttel AS, Gromov M, Guffanti D, Ianni A, Ianni A, Jany A, Kobychev V, Korga G, Kumaran S, Laubenstein M, Litvinovich E, Lombardi P, Lomskaya I, Ludhova L, Lukyanchenko G, Machulin I, Martyn J, Meroni E, Miramonti L, Misiaszek M, Muratova V, Nugmanov R, Oberauer L, Orekhov V, Ortica F, Pallavicini M, Papp L, Pelicci L, Penek Ö, Pietrofaccia L, Pilipenko N, Pocar A, Raikov G, Ranalli MT, Ranucci G, Razeto A, Re A, Redchuk M, Rossi N, Schönert S, Semenov D, Settanta G, Skorokhvatov M, Singhal A, Smirnov O, Sotnikov A, Tartaglia R, Testera G, Unzhakov E, Villante FL, Vishneva A, Vogelaar RB, von Feilitzsch F, Wojcik M, Wurm M, Zavatarelli S, Zuber K, Zuzel G. Improved Measurement of Solar Neutrinos from the Carbon-Nitrogen-Oxygen Cycle by Borexino and Its Implications for the Standard Solar Model. Phys Rev Lett 2022; 129:252701. [PMID: 36608219 DOI: 10.1103/physrevlett.129.252701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/14/2022] [Revised: 09/01/2022] [Accepted: 10/05/2022] [Indexed: 06/17/2023]
Abstract
We present an improved measurement of the carbon-nitrogen-oxygen (CNO) solar neutrino interaction rate at Earth obtained with the complete Borexino Phase-III dataset. The measured rate, R_{CNO}=6.7_{-0.8}^{+2.0} counts/(day×100 tonnes), allows us to exclude the absence of the CNO signal with about 7σ C.L. The correspondent CNO neutrino flux is 6.6_{-0.9}^{+2.0}×10^{8} cm^{-2} s^{-1}, taking into account the neutrino flavor conversion. We use the new CNO measurement to evaluate the C and N abundances in the Sun with respect to the H abundance for the first time with solar neutrinos. Our result of N_{CN}=(5.78_{-1.00}^{+1.86})×10^{-4} displays a ∼2σ tension with the "low-metallicity" spectroscopic photospheric measurements. Furthermore, our result used together with the ^{7}Be and ^{8}B solar neutrino fluxes, also measured by Borexino, permits us to disfavor at 3.1σ C.L. the "low-metallicity" standard solar model B16-AGSS09met as an alternative to the "high-metallicity" standard solar model B16-GS98.
Collapse
Affiliation(s)
- S Appel
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - Z Bagdasarian
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
| | - D Basilico
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - G Bellini
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - J Benziger
- Chemical Engineering Department, Princeton University, Princeton, New Jersey 08544, USA
| | - R Biondi
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - B Caccianiga
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - F Calaprice
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A Caminata
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - P Cavalcante
- Physics Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - A Chepurnov
- Lomonosov Moscow State University Skobeltsyn Institute of Nuclear Physics, 119234 Moscow, Russia
| | - D D'Angelo
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - A Derbin
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - A Di Giacinto
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - V Di Marcello
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - X F Ding
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A Di Ludovico
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - L Di Noto
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - I Drachnev
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - D Franco
- AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, Sorbonne Paris Cité, 75205 Paris Cedex 13, France
| | - C Galbiati
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
- Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - C Ghiano
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - M Giammarchi
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - A Goretti
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A S Göttel
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - M Gromov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
- Lomonosov Moscow State University Skobeltsyn Institute of Nuclear Physics, 119234 Moscow, Russia
| | - D Guffanti
- Institute of Physics and Excellence Cluster PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - Aldo Ianni
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - Andrea Ianni
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A Jany
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - V Kobychev
- Kiev Institute for Nuclear Research, 03680 Kiev, Ukraine
| | - G Korga
- Department of Physics, Royal Holloway University of London, Egham, Surrey,TW20 0EX, United Kingdom
- Institute of Nuclear Research (Atomki), Debrecen, Hungary
| | - S Kumaran
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - M Laubenstein
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - E Litvinovich
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - P Lombardi
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - I Lomskaya
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - L Ludhova
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - G Lukyanchenko
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
| | - I Machulin
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - J Martyn
- Institute of Physics and Excellence Cluster PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - E Meroni
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - L Miramonti
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - M Misiaszek
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - V Muratova
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - R Nugmanov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - L Oberauer
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - V Orekhov
- Institute of Physics and Excellence Cluster PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - F Ortica
- Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi e INFN, 06123 Perugia, Italy
| | - M Pallavicini
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - L Papp
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - L Pelicci
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - Ö Penek
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
| | - L Pietrofaccia
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - N Pilipenko
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - A Pocar
- Amherst Center for Fundamental Interactions and Physics Department, University of Massachusetts, Amherst, Massachusetts 01003, USA
| | - G Raikov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
| | - M T Ranalli
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - G Ranucci
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - A Razeto
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - A Re
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - M Redchuk
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - N Rossi
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - S Schönert
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - D Semenov
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - G Settanta
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
| | - M Skorokhvatov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - A Singhal
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - O Smirnov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - A Sotnikov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - R Tartaglia
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - G Testera
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - E Unzhakov
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - F L Villante
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
- Dipartimento di Scienze Fisiche e Chimiche, Università dell'Aquila, 67100 L'Aquila, Italy
| | - A Vishneva
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - R B Vogelaar
- Physics Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - F von Feilitzsch
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - M Wojcik
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - M Wurm
- Institute of Physics and Excellence Cluster PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - S Zavatarelli
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - K Zuber
- Department of Physics, Technische Universität Dresden, 01062 Dresden, Germany
| | - G Zuzel
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| |
Collapse
|
6
|
Iezzi M, Cusumano D, Piccari D, Menna S, Catucci F, D'Aviero A, Re A, Di Dio C, Quaranta F, Boschetti A, Marras M, Piro D, Votta C, Sanna E, Flore C, Mattiucci G, Valentini V. PO-1483 A predictive model to quantify the dosimetric impact of inter-fraction variability in breast cancer. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03447-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
7
|
Boschetti A, Votta C, Re A, Piro D, Marras M, D'Aviero A, Catucci F, Cusumano D, Di Dio C, Menna S, Iezzi M, Quaranta F, Flore C, Sanna E, Piccari D, Mattiucci G, Valentini V. PD-0336 Evaluation of a deep-learning segmentation software in thoracic organs at risk: an early analysis. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02829-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
8
|
Piro D, Marras M, D'Aviero A, Boschetti A, Votta C, Re A, Catucci F, Cusumano D, Di Dio C, Menna S, Iezzi M, Quaranta F, Flore C, Sanna E, Piccari D, Mattiucci G, Valentini V. PO-1887 Validation of deep learning auto-segmentation in pelvic organs at risk: a preliminary analysis. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03850-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
9
|
Agostini M, Altenmüller K, Appel S, Atroshchenko V, Bagdasarian Z, Basilico D, Bellini G, Benziger J, Biondi R, Bravo D, Caccianiga B, Calaprice F, Caminata A, Cavalcante P, Chepurnov A, D'Angelo D, Davini S, Derbin A, Di Giacinto A, Di Marcello V, Ding XF, Di Ludovico A, Di Noto L, Drachnev I, Formozov A, Franco D, Galbiati C, Ghiano C, Giammarchi M, Goretti A, Göttel AS, Gromov M, Guffanti D, Ianni A, Ianni A, Jany A, Jeschke D, Kobychev V, Korga G, Kumaran S, Laubenstein M, Litvinovich E, Lombardi P, Lomskaya I, Ludhova L, Lukyanchenko G, Lukyanchenko L, Machulin I, Martyn J, Meroni E, Meyer M, Miramonti L, Misiaszek M, Muratova V, Neumair B, Nieslony M, Nugmanov R, Oberauer L, Orekhov V, Ortica F, Pallavicini M, Papp L, Pelicci L, Penek Ö, Pietrofaccia L, Pilipenko N, Pocar A, Raikov G, Ranalli MT, Ranucci G, Razeto A, Re A, Redchuk M, Romani A, Rossi N, Schönert S, Semenov D, Settanta G, Skorokhvatov M, Singhal A, Smirnov O, Sotnikov A, Suvorov Y, Tartaglia R, Testera G, Thurn J, Unzhakov E, Vishneva A, Vogelaar RB, von Feilitzsch F, Wessel A, Wojcik M, Wonsak B, Wurm M, Zavatarelli S, Zuber K, Zuzel G. First Directional Measurement of Sub-MeV Solar Neutrinos with Borexino. Phys Rev Lett 2022; 128:091803. [PMID: 35302807 DOI: 10.1103/physrevlett.128.091803] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2021] [Accepted: 01/25/2022] [Indexed: 06/14/2023]
Abstract
We report the measurement of sub-MeV solar neutrinos through the use of their associated Cherenkov radiation, performed with the Borexino detector at the Laboratori Nazionali del Gran Sasso. The measurement is achieved using a novel technique that correlates individual photon hits of events to the known position of the Sun. In an energy window between 0.54 to 0.74 MeV, selected using the dominant scintillation light, we have measured 10 887_{-2103}^{+2386}(stat)±947(syst) (68% confidence interval) solar neutrinos out of 19 904 total events. This corresponds to a ^{7}Be neutrino interaction rate of 51.6_{-12.5}^{+13.9} counts/(day·100 ton), which is in agreement with the standard solar model predictions and the previous spectroscopic results of Borexino. The no-neutrino hypothesis can be excluded with >5σ confidence level. For the first time, we have demonstrated the possibility of utilizing the directional Cherenkov information for sub-MeV solar neutrinos, in a large-scale, high light yield liquid scintillator detector. This measurement provides an experimental proof of principle for future hybrid event reconstruction using both Cherenkov and scintillation signatures simultaneously.
Collapse
Affiliation(s)
- M Agostini
- Physik-Department, Technische Universität München, 85748 Garching, Germany
- Department of Physics and Astronomy, University College London, London, WC1E 6BT, United Kingdom
| | - K Altenmüller
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - S Appel
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - V Atroshchenko
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
| | - Z Bagdasarian
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
| | - D Basilico
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - G Bellini
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - J Benziger
- Chemical Engineering Department, Princeton University, Princeton, New Jersey 08544, USA
| | - R Biondi
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - D Bravo
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - B Caccianiga
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - F Calaprice
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A Caminata
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - P Cavalcante
- Physics Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - A Chepurnov
- Lomonosov Moscow State University Skobeltsyn Institute of Nuclear Physics, 119234 Moscow, Russia
| | - D D'Angelo
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - S Davini
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - A Derbin
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - A Di Giacinto
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - V Di Marcello
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - X F Ding
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A Di Ludovico
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - L Di Noto
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - I Drachnev
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - A Formozov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - D Franco
- APC, Université de Paris, CNRS, Astroparticule et Cosmologie, Paris F-75013, France
| | - C Galbiati
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
- Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - C Ghiano
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - M Giammarchi
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - A Goretti
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A S Göttel
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - M Gromov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
- Lomonosov Moscow State University Skobeltsyn Institute of Nuclear Physics, 119234 Moscow, Russia
| | - D Guffanti
- Institute of Physics and Cluster of Excellence PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - Aldo Ianni
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - Andrea Ianni
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A Jany
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - D Jeschke
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - V Kobychev
- Institute for Nuclear Research of NAS Ukraine, 03028 Kyiv, Ukraine
| | - G Korga
- Department of Physics, School of Engineering, Physical and Mathematical Sciences, Royal Holloway, University of London, Egham, TW20 OEX, United Kingdom
- Institute of Nuclear Research (Atomki), 4026, Debrecen, Hungary
| | - S Kumaran
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - M Laubenstein
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - E Litvinovich
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - P Lombardi
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - I Lomskaya
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - L Ludhova
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - G Lukyanchenko
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
| | - L Lukyanchenko
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
| | - I Machulin
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - J Martyn
- Institute of Physics and Cluster of Excellence PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - E Meroni
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - M Meyer
- Department of Physics, Technische Universität Dresden, 01062 Dresden, Germany
| | - L Miramonti
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - M Misiaszek
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - V Muratova
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - B Neumair
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - M Nieslony
- Institute of Physics and Cluster of Excellence PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - R Nugmanov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - L Oberauer
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - V Orekhov
- Institute of Physics and Cluster of Excellence PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - F Ortica
- Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi e INFN, 06123 Perugia, Italy
| | - M Pallavicini
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - L Papp
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - L Pelicci
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - Ö Penek
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
| | - L Pietrofaccia
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - N Pilipenko
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - A Pocar
- Amherst Center for Fundamental Interactions and Physics Department, UMass, Amherst, Massachusetts 01003, USA
| | - G Raikov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
| | - M T Ranalli
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - G Ranucci
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - A Razeto
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - A Re
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - M Redchuk
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - A Romani
- Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi e INFN, 06123 Perugia, Italy
| | - N Rossi
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - S Schönert
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - D Semenov
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - G Settanta
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
| | - M Skorokhvatov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - A Singhal
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - O Smirnov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - A Sotnikov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - Y Suvorov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - R Tartaglia
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - G Testera
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - J Thurn
- Department of Physics, Technische Universität Dresden, 01062 Dresden, Germany
| | - E Unzhakov
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - A Vishneva
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - R B Vogelaar
- Physics Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - F von Feilitzsch
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - A Wessel
- GSI Helmholtzzentrum für Schwerionenforschung, Planckstrasse 1, D-64291 Darmstadt, Germany
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - M Wojcik
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - B Wonsak
- University of Hamburg, Institute of Experimental Physics, Luruper Chaussee 149, 22761 Hamburg, Germany
| | - M Wurm
- Institute of Physics and Cluster of Excellence PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - S Zavatarelli
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - K Zuber
- Department of Physics, Technische Universität Dresden, 01062 Dresden, Germany
| | - G Zuzel
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| |
Collapse
|
10
|
Cattaneo C, Cancelli V, Imberti L, Dobbs K, Sottini A, Pagani C, Belotti A, Re A, Anastasia A, Quaresima V, Tucci A, Chiorini JA, Su HC, Cohen JI, Burbelo PD, Rossi G, Notarangelo LD. Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab. Blood Cancer J 2021; 11:151. [PMID: 34521813 PMCID: PMC8438656 DOI: 10.1038/s41408-021-00546-9] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2021] [Revised: 08/14/2021] [Accepted: 08/27/2021] [Indexed: 12/17/2022] Open
Abstract
The ability of patients with hematologic malignancies (HM) to develop an effective humoral immune response after COVID-19 is unknown. A prospective study was performed to monitor the immune response to SARS-CoV-2 of patients with follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), chronic lymphoproliferative disorders (CLD), multiple myeloma (MM), or myelodysplastic/myeloproliferative syndromes (MDS/MPN). Antibody (Ab) levels to the SARS-CoV-2 nucleocapsid (N) and spike (S) protein were measured at +1, +3, +6 months after nasal swabs became PCR-negative. Forty-five patients (9 FL, 8 DLBCL, 8 CLD, 10 MM, 10 MDS/MPS) and 18 controls were studied. Mean anti-N and anti-S-Ab levels were similar between HM patients and controls, and shared the same behavior, with anti-N Ab levels declining at +6 months and anti-S-Ab remaining stable. Seroconversion rates were lower in HM patients than in controls. In lymphoma patients mean Ab levels and seroconversion rates were lower than in other HM patients, primarily because all nine patients who had received rituximab within 6 months before COVID-19 failed to produce anti-N and anti-S-Ab. Only one patient requiring hematological treatment after COVID-19 lost seropositivity after 6 months. No reinfections were observed. These results may inform vaccination policies and clinical management of HM patients.
Collapse
Affiliation(s)
- C Cattaneo
- Hematology, ASST Spedali Civili, Brescia, Italy.
| | - V Cancelli
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - L Imberti
- CREA (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy
| | - K Dobbs
- Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - A Sottini
- CREA (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy
| | - C Pagani
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - A Belotti
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - A Re
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - A Anastasia
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - V Quaresima
- CREA (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy
| | - A Tucci
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - J A Chiorini
- National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, USA
| | - H C Su
- Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - J I Cohen
- Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD, USA
| | - P D Burbelo
- National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, USA
| | - G Rossi
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - L D Notarangelo
- Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| |
Collapse
|
11
|
Pezzulla D, Macchia G, Cilla S, Boccardi M, Re A, Bonome P, Picardi V, Ferro M, Romano C, Buwenge M, Cammelli S, Valentini V, Valenti V, Morganti A, Deodato F. PD-0887 VMAT Radiotherapy boost in oligometastatic patients with Spinal Metastases: a dose escalation study. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07166-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
12
|
Bisello S, Arcelli A, Deodato F, Dominsky N, Tarantino G, Ntreta M, Cilla S, Siepe G, Cavallini L, Pezzulla D, Alitto A, Re A, Cammelli S, Cortesi A, Romeo A, Frezza G, Morganti A, Macchia G, Buwenge M. PO-1392 Salvage radiotherapy of prostate cancer: a risk stratification system based on prognostic factors. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07843-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
13
|
Zamagni A, Bonetti M, Buwenge M, Ntreta M, Tolento G, Cammelli S, Donati C, Lodi Rizzini E, Boccardi M, Re A, Deodato F, Cilla S, Macchia G, Morganti A. PO-1394 Stereotactic body radiotherapy for prostate cancer lymph node metastases: a systematic review. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07845-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
14
|
Bisello S, Arcelli A, Deodato F, Dominsky N, Tarantino G, Ntreta M, Cilla S, Siepe G, Cavallini L, Pezzulla D, Alitto A, Re A, Cammelli S, Cortesi A, Romeo A, Frezza G, Morganti A, Macchia G, Buwenge M. PO-1380 Adjuvant radiotherapy of prostate cancer: a risk stratification system based on prognostic factors. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07831-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
15
|
Tucci A, Musuraca G, Cavallo F, Zilioli VR, Zanni M, Pelliccia S, Mannina D, Michieli M, Vallisa D, Tani M, Merli F, Re F, Marcheselli L, Campostrini G, Pagani C, Grimaldi D, Liardo EV, Re A, Cox MC, Rossi G. AUTOLOGOUS TRANSPLANT IN ELDERLY PATIENTS WITH R/R AGGRESSIVE LYMPHOMA SELECTED BY SIMPLIFIED CGA: THE RECANZ PROSPECTIVE PHASE 2 STUDY BY THE FONDAZIONE ITALIANA LINFOMI. Hematol Oncol 2021. [DOI: 10.1002/hon.99_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- A Tucci
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - G Musuraca
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" Hematology Unit Meldola (FC) Italy
| | - F Cavallo
- University of To‐rino/AOU “Città della Salute e della Scienza di Torino” Division of Hematology, Department of Molecular Biotechnologies and Health Sciences Torino Italy
| | - V. R Zilioli
- ASST Grande Ospedale Metropolitano Niguarda Division of Hematology Milano Italy
| | - M Zanni
- A.O. SS. Antonio e Biagio e Cesare Arrigo Division of Hematology Alessandria Italy
| | - S Pelliccia
- Hospital Sant’Andrea – Sapienza, Rome Hematology University Roma Italy
| | - D Mannina
- Azienda Ospedaliera Papardo Unit of Hematology Messina Italy
| | - M Michieli
- Aviano (PN) Haematology Transplant and Cell Therapy Unit Aviano (PN) Italy
| | - D Vallisa
- Ospedale Guglielmo da Saliceto Division of Hematology Piacenza Italy
| | - M Tani
- Ospedale delle Croci Department of Hematology Ravenna Italy
| | - F Merli
- Azienda Unità Sanitaria Locale – IRCCS Hematology Unit Reggio Emilia Italy
| | - F Re
- AOU di Parma Hematology Unit Parma Italy
| | - L Marcheselli
- Fondazione Italiana Linfomi Onlus Fondazione Italiana Linfomi Onlus Modena Italy
| | - G Campostrini
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - C Pagani
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - D Grimaldi
- University of To‐rino/AOU “Città della Salute e della Scienza di Torino” Division of Hematology, Department of Molecular Biotechnologies and Health Sciences Torino Italy
| | - E. V Liardo
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" Hematology Unit Meldola (FC) Italy
| | - A Re
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - M. C Cox
- University Hospital Sant’Andrea – Sapienza Hematology Roma Italy
| | - G Rossi
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| |
Collapse
|
16
|
Chiappella A, Carniti C, Re A, Castellino C, Evangelista A, Ciancia R, Orsucci L, Pinto A, Usai SV, Arcari A, Ilariucci F, Rossi FG, Benedetti F, Flenghi L, Ghiggi C, Molinari AL, Stefoni V, Volpetti S, Zilioli VR, Ballerini F, Bruna R, Cavallo F, Musuraca G, Patti C, Re F, Tani M, Varettoni M, Zanni M, Dodero A, Pileri SA, Ciccone G, Corradini P. ROMIDEPSIN‐CHOEP PLUS UP‐FRONT STEM‐CELL TRANSPLANTATION IN PERIPHERAL T‐CELL LYMPHOMA (PTCL): FIRST ANALYSIS OF THE PHASE II FIL‐PTCL13 STUDY. Hematol Oncol 2021. [DOI: 10.1002/hon.130_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- A. Chiappella
- Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Hematology and Stem Cell Transplantation Milano Italy
| | - C. Carniti
- Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano Laboratory of Hematology Division of Hematology and Stem Cell Transplantation Milano Italy
| | - A. Re
- ASST Spedali Civili di Brescia Hematology Division Brescia Italy
| | - C. Castellino
- Azienda Ospedaliera S. Croce e Carle Division of Hematology Cuneo Italy
| | - A. Evangelista
- Azienda Ospedaliera e Universitaria Città della Salute e della Scienza and CPO Piemonte Unit of Clinical Epidemiology Torino Italy
| | - R. Ciancia
- Centro di Riferimento Oncologico (CRO) IRCCS Onco‐hematology and Stem Cell Transplantation and Cellular Therapies Aviano Italy
| | - L. Orsucci
- Azienda Ospedaliera e Universitaria Città della Salute e della Scienza Division of Hematology Torino Italy
| | - A. Pinto
- Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS Hematology‐Oncology & Stem Cell Transplantation Unit Napoli Italy
| | - S. V. Usai
- Ospedale Oncologico Armando Businco Hematology Cagliari Italy
| | - A. Arcari
- Ospedale Guglielmo da Saliceto Hematology Unit Piacenza Italy
| | - F. Ilariucci
- Azienda USL‐IRCCS, Hematology Reggio Emilia Italy
| | - F. G. Rossi
- Fondazione IRCCS Cà Granda OM Policlinico Division of Hematology Milano Italy
| | - F. Benedetti
- Azienda Ospedaliera Universitaria di Verona Hematology and Stem Cell Transplantation Verona Italy
| | - L. Flenghi
- Azienda Ospedaliera di Perugia Hematology Perugia Italy
| | - C. Ghiggi
- IRCCS Ospedale Policlinico San Martino Hematology Genova Italy
| | | | - V. Stefoni
- University of Bologna Institute of Hematology "Seràgnoli" Bologna Italy
| | - S. Volpetti
- Presidio Ospedaliero Universitario "Santa Maria della Misericordia” di Udine ASUFC Clinic of Hematology Udine Italy
| | - V. R. Zilioli
- ASST Grande Ospedale Metropolitano Niguarda Division of Hematology Milano Italy
| | - F. Ballerini
- IRCCS Ospedale Policlinico San Martino Clinic of Hematology Genova Italy
| | - R. Bruna
- Ospedale Maggiore Della Carità Division of Hematology Novara Italy
| | - F. Cavallo
- University of Torino Azienda Ospedaliera e Universitaria Città della Salute e della Scienza Division of Hematology Department of Molecular Biotechnologies and Health Sciences Torino Italy
| | - G. Musuraca
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" Division of Hematology Meldola Italy
| | - C. Patti
- Azienda Villa Sofia Cervello Division of Onco‐Hematology Palermo Italy
| | - F. Re
- Azienda Ospedaliera‐Universitaria di Parma Hematology and CTMO Parma Italy
| | - M. Tani
- Ospedale Santa Maria delle Croci Hematology Unit Ravenna Italy
| | - M. Varettoni
- Fondazione IRCCS Policlinico San Matteo Division of Hematology Pavia Italy
| | - M. Zanni
- Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo Division of Hematology Alessandria Italy
| | - A. Dodero
- Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Hematology and Stem Cell Transplantation Milano Italy
| | - S. A. Pileri
- European Institute of Oncology IRCCS Division of Haematopathology Milano Italy
| | - G. Ciccone
- Azienda Ospedaliera e Universitaria Città della Salute e della Scienza and CPO Piemonte Unit of Clinical Epidemiology Torino Italy
| | - P. Corradini
- Chair of Hematology University of Milano Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Division of Hematology and Stem Cell Transplantation Milano Italy
| |
Collapse
|
17
|
Tucci A, Merli F, Fabbri A, Mancuso S, Sartori R, Storti S, Luminari S, Mammi C, Marcheselli L, Arcari A, Cavallo F, Zilioli VR, Bottelli C, Re A, Gini G, Cox MC, Puccini B, Pagani C, Balzarotti M, Spina M, Rossi G. DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN LATE‐OCTOGENARIAN (LO) PATIENTS: A SUBSTUDY OF THE “ELDERLY PROJECT” BY THE FONDAZIONE ITALIANA LINFOMI (FIL). Hematol Oncol 2021. [DOI: 10.1002/hon.95_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- A. Tucci
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - F. Merli
- Azienda Unità Sanitaria Locale – IRCCS Hematology Unit Reggio Emilia Italy
| | - A. Fabbri
- zienda Ospedaliera Universitaria Senese and University of Siena Unit of Hematology Siena Italy
| | - S. Mancuso
- Department Pro.Mi.Se Univeristy of Palermo Haematology Division Palermo Italy
| | - R. Sartori
- Veneto Institute of Oncology IOV‐IRCCS Department of Clinical and Experimental Oncology Oncohematology Unit Castelfranco Veneto (TV) Italy
| | - S. Storti
- Università Cattolica Onco‐hematology Unit Campobasso‐Roma Italy
| | - S. Luminari
- University of Modena and Reggio Emilia Azienda Unità Sanitaria Locale – IRCCS Department CHIMOMO Hematology Unit Reggio Emilia Italy
| | - C. Mammi
- Gruppo Amici dell'Ematologia GRADE‐ Onlus Foundation Hematology Unit Reggio Emilia Italy
| | - L. Marcheselli
- Fondazione Italiana Linfomi Onlus Fondazione Italiana Linfomi Onlus Modena Italy
| | - A. Arcari
- Ospedale Guglielmo da Saliceto Hematology Unit Piacenza Italy
| | - F. Cavallo
- University of Torino/AOU “Città della Salute e della Scienza di Torino” Division of Hematology Department of Molecular Biotechnologies and Health Sciences Torino Italy
| | - V. R. Zilioli
- ASST Grande Ospedale Metropolitano Niguarda Division of Hematology Milano Italy
| | - C. Bottelli
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - A. Re
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - G. Gini
- Azienda Ospedaliera Universitaria Ospedali Riuniti Division of Hematology Ancona Italy
| | - M. C. Cox
- Azienda Ospedaliera Universitaria S.Andrea Hematology Unit Roma Italy
| | - B. Puccini
- Careggi University Hospital Hematology Unit Firenze Italy
| | - C. Pagani
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - M. Balzarotti
- Humanitas Clinical Research Hospital‐IRCCS Department of Medical Oncology and Hematology Rozzano (MI) Italy
| | - M. Spina
- Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Division of Medical Oncology and Immune‐related Tumors Aviano (PN) Italy
| | - G. Rossi
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| |
Collapse
|
18
|
Merli F, Tucci A, Arcari A, Rigacci L, Cavallo F, Cabras G, Alvarez I, Fabbri A, Re A, Ferrero S, Puccini B, Usai SV, Ferrari A, Cencini E, Pennese E, Zilioli VR, Marino D, Balzarotti M, Cox MC, Zanni M, Rocco A, Lleshi A, Botto B, Hohaus S, Merli M, Sartori R, Gini G, Nassi L, Musuraca G, Tani M, Bottelli C, Kovalchuk S, Re F, Flenghi L, Molinari A, Tarantini G, Chimienti E, Marcheselli L, Mammi C, Luminari S, Spina M. THE ELDERLY PROGNOSTIC INDEX (EPI) PREDICTS EARLY MORTALITY IN OLDER PATIENTS WITH DLBCL. A SUBSTUDY OF THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI (FIL). Hematol Oncol 2021. [DOI: 10.1002/hon.85_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
19
|
Re A, Cilla S, Ferro M, Ianiro A, Macchia G, Picardi V, Boccardi M, Cammelli S, Romano C, D'Addario D, Buwenge M, Mignogna S, Ferro M, Valentini V, Sallustio G, Morganti A, Deodato F. PO-0794: Induction chemotherapy followed by moderately accelerated IMRT in head and neck cancer patients. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00811-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
20
|
Ferro M, Ianiro A, Re A, Macchia G, Cilla S, Picardi V, Boccardi M, Ferro M, Cammelli S, Romano C, Bisello S, Buwenge M, Mignogna S, Giglio G, Cucci E, Valentini V, Morganti A, Deodato F. OC-0091: SIB accelerated RT and concomitant TMZ in GBM patients: results of a phase I study (ISIDE BT-2). Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00117-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
21
|
Alitto A, Buwenge M, Macchia G, Ntreta M, Siepe G, Galofaro E, Bertini F, Ferioli M, Mazzeo E, Ippolito E, Mantini G, Ferro M, Re A, Cilla S, Valentini V, Deodato F, Morganti A, Cammelli S. PO-1185: Results of prostate cancer patients treated by integrated boost to dominant intraprostatic lesion. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)01203-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
22
|
Deodato F, Re A, Ianiro A, Ferro M, Macchia G, Picardi V, Boccardi M, Buwenge M, Assalone P, Berardinelli F, Maselli G, Cammelli S, Ferro M, Romano C, Mignogna S, Valentini V, Morganti A, Cilla S. PD-0667: Early analysis from two phase I trials on SBRT of isolated nodal recurrences in prostate patients. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00689-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
23
|
Ferioli M, Panni V, Galuppi A, Zamagni A, Buwenge M, Macchia G, Deodato F, Re A, Boccardi M, Cilla S, Fanti S, Morganti A, Cammelli S. PO-1134: 18F-FDG-PET/CT role in the adjuvant setting of endometrial cancer. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)01151-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
24
|
Re A, Picardi V, Deodato F, Ianiro A, Cilla S, Boccardi M, Ferro M, Arcelli A, Buwenge M, Cammelli S, Romano C, Restaino G, Ferro M, Specchia M, Guido A, Mignogna S, Valentini V, Morganti A, Macchia G. PO-1083: Efficacy and tolerance of VMAT-SIB intensified neoadjuvant chemoradiation in rectal cancer patients. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)01100-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
25
|
Macchia G, Cerrotta A, Deodato F, Pappalardi B, Re A, Santoni R, Campitelli M, Scambia G, Valentini V, Aristei C, Ferrandina G. PO-1116: Cervical cancer patterns of care in italy: a radiation oncology survey of mito and airo gyn groups. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)01133-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
26
|
Agostini M, Altenmüller K, Appel S, Atroshchenko V, Bagdasarian Z, Basilico D, Bellini G, Benziger J, Bick D, Bravo D, Caccianiga B, Calaprice F, Caminata A, Cavalcante P, Chepurnov A, D’Angelo D, Davini S, Derbin A, Di Giacinto A, Di Marcello V, Ding X, Di Ludovico A, Di Noto L, Drachnev I, Formozov A, Franco D, Galbiati C, Gschwender M, Ghiano C, Giammarchi M, Goretti A, Gromov M, Guffanti D, Hagner C, Houdy T, Hungerford E, Ianni A, Ianni A, Jany A, Jeschke D, Kobychev V, Korga G, Kumaran S, Lachenmaier T, Laubenstein M, Litvinovich E, Lombardi P, Lomskaya I, Ludhova L, Lukyanchenko G, Lukyanchenko L, Machulin I, Marcocci S, Martyn J, Meroni E, Meyer M, Miramonti L, Misiaszek M, Muratova V, Neumair B, Nieslony M, Nugmanov R, Oberauer L, Orekhov V, Ortica F, Pallavicini M, Papp L, Penek Ö, Pietrofaccia L, Pilipenko N, Pocar A, Raikov G, Ranalli M, Ranucci G, Razeto A, Re A, Redchuk M, Romani A, Rossi N, Rottenanger S, Schönert S, Semenov D, Skorokhvatov M, Smirnov O, Sotnikov A, Suvorov Y, Tartaglia R, Testera G, Thurn J, Unzhakov E, Vishneva A, Vogelaar R, von Feilitzsch F, Wojcik M, Wurm M, Zavatarelli S, Zuber K, Zuzel G. Improved measurement of
B8
solar neutrinos with
1.5 kt·y
of Borexino exposure. Int J Clin Exp Med 2020. [DOI: 10.1103/physrevd.101.062001] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
27
|
Rusconi C, Tucker D, Bernard S, Muzi C, Crucitti L, Stefani P, Cox M, Gini G, Re A, Sciarra R, Liberati A, Morello L, Arcari A, Mannina D, Vitagliano O, Sartori R, Chiappella A, Balzarotti M, Vitolo U, Thieblemont C, Rule S, Visco C. IBRUTINIB COMPARED TO STANDARD CHEMOTHERAPY FOR CENTRAL NERVOUS SYSTEM RECURRENCE OF MANTLE CELL LYMPHOMA. Hematol Oncol 2019. [DOI: 10.1002/hon.54_2630] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- C. Rusconi
- Division of Hematology; ASST Grande Ospedale Metropolitano Niguarda; Milan Italy
| | - D. Tucker
- Department of Haematology; Royal Cornwall NHSTrust; Truro Cornwall United Kingdom
| | - S. Bernard
- Service d'Onco-Hématologie; Hôpital Saint-Louis, AP-HP; Paris France
| | - C. Muzi
- Division of Hematology; ASST Grande Ospedale Metropolitano Niguarda; Milan Italy
| | - L. Crucitti
- Division of Hematology; ASST Grande Ospedale Metropolitano Niguarda; Milan Italy
| | - P. Stefani
- U.O.C. di Ematologia; Dipartimento di Medicina Specialistica, Unità Locale Socio-Sanitaria della Marca Trevigiana; Treviso Italy
| | - M. Cox
- Haematology Unit, Department of Clinical and Experimental Medicine; Sapienza University, AO Sant'Andrea; Rome Italy
| | - G. Gini
- Division of Hematology; Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona; Ancona Italy
| | - A. Re
- U.O. Ematologia; Spedali Civili di Brescia; Brescia Italy
| | - R. Sciarra
- Division of Hematology; Fondazione IRCCS Policlinico San Matteo; Pavia Italy
| | - A. Liberati
- Università di Perugia; AO Santa Maria di Terni; Terni Italy
| | - L. Morello
- Department of Medica Oncology and Hematology; Humanitas Clinical and Research Center - IRCCS; Rozzano Milan Italy
| | - A. Arcari
- Hematology Unit; Ospedale Guglielmo da Saliceto; Piacenza Italy
| | - D. Mannina
- UOC di Ematologia; Azienda Ospedaliera Papardo; Messina Italy
| | - O. Vitagliano
- Division of Hematology; Cardarelli Hospital; Naples Italy
| | - R. Sartori
- Hematology Department; Castelfranco Veneto Hospital, ULSS 2 Marca Trevigiana, Castelfranco Veneto; Treviso Italy
| | - A. Chiappella
- Hematology; AO Città della Salute e della Scienza di Torino; Turin Italy
| | - M. Balzarotti
- Department of Medica Oncology and Hematology; Humanitas Clinical and Research Center - IRCCS; Rozzano Milan Italy
| | - U. Vitolo
- Hematology; AO Città della Salute e della Scienza di Torino; Turin Italy
| | - C. Thieblemont
- Service d'Onco-Hématologie; Hôpital Saint-Louis, AP-HP; Paris France
| | - S. Rule
- Plymouth University; Peninsula Schools of Medicine ad Dentistry; Plymouth United Kingdom
| | - C. Visco
- Department of Medicine; Section of Hematology, University of Verona; Verona Italy
| |
Collapse
|
28
|
Chiappella A, Carniti C, Evangelista A, Re A, Cabras M, Stefoni V, Castellino C, Congiu A, Pinto A, Zanni M, Rusconi C, Molinari A, Ciancia R, Baldini L, Nassi L, Re F, Tani M, Ilariucci F, Cavallo F, Santoro A, Volpetti S, Dodero A, Pileri S, Ciccone G, Corradini P. PHASE II FIL-PTCL13 STUDY OF ROMIDEPSIN-CHOEP FOLLOWED BY HIGH-DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T-CELL LYMPHOMAS. Hematol Oncol 2019. [DOI: 10.1002/hon.3_2632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- A. Chiappella
- Ematologia; AOU Città della Salute e della Scienza di Torino; Torino Italy
| | - C. Carniti
- Ematologia; Università degli Studi di Milano; Milano Italy
| | - A. Evangelista
- SSD Epidemiologia Clinica e Valutativa; Clinical Trial Center, AOU Città della Salute e della Scienza di Torino e CPO Piemonte; Torino Italy
| | - A. Re
- Ematologia; ASTT Spedali Civili di Brescia; Brescia Italy
| | - M.G. Cabras
- Ematologia; Ospedale Oncologico Armando Businco; Cagliari Italy
| | - V. Stefoni
- Ematologia; Policlinico S.Orsola-Malpighi, Istituto di Ematologia "Seragnoli"; Bologna Italy
| | - C. Castellino
- Ematologia e Trapianto di Midollo Osseo; AO Santa Croce e Carle; Cuneo Italy
| | - A.G. Congiu
- Ematologia; Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia; Genova Italy
| | - A. Pinto
- Ematologia Oncologica; Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale; Napoli Italy
| | - M. Zanni
- Ematologia; AO SS Antonio e Biagio e Cesare Arrigo; Alessandria Italy
| | - C. Rusconi
- Ematologia; ASST Grande Ospedale Metropolitano Niguarda; Milano Italy
| | | | - R. Ciancia
- Oncoematologia; trapianti emopoietici e terapie cellulari, Centro di Riferimento Oncologico CRO, IRCCS; Aviano Italy
| | - L. Baldini
- Ematologia; Ospedale Maggiore Policlinico - Fondazione IRCCS Ca' Granda; Milano Italy
| | - L. Nassi
- Ematologia; AOU Maggiore della Carità di Novara; Novara Italy
| | - F. Re
- Ematologia e CTMO; AOU Ospedale Maggiore di Parma; Parma Italy
| | - M. Tani
- Ematologia; Ospedale Santa Maria delle Croci; Ravenna Italy
| | - F. Ilariucci
- Ematologia; Azienda Ospedaliera Arcispedale Santa Maria Nuova - IRCCS; Reggio Emilia Italy
| | - F. Cavallo
- Ematologia; Università degli Studi - AOU Città della Salute e della Scienza di Torino; Torino Italy
| | - A. Santoro
- Ematologia; Istituto Clinico Humanitas; Rozzano Italy
| | - S. Volpetti
- Ematologia; ASUI Santa Maria della Misericordia; Udine Italy
| | - A. Dodero
- Ematologia; Fondazione IRCCS Istituto Nazionale dei Tumori; Milano Italy
| | - S.A. Pileri
- Emopatologia; Istituto Europeo Oncologico IRCCS; Milano Italy
| | - G. Ciccone
- SSD Epidemiologia Clinica e Valutativa; Clinical Trial Center, AOU Città della Salute e della Scienza di Torino e CPO Piemonte; Torino Italy
| | - P. Corradini
- Ematologia; Fondazione IRCCS Istituto Nazionale dei Tumori - Università degli Studi di Milano; Milano Italy
| |
Collapse
|
29
|
Ferreri A, Sassone M, Angelillo P, Zaja F, Re A, Spina M, Di Rocco A, Fabbri A, Stelitano C, Frezzato M, Rusconi C, Zambello R, Arcari A, Bertoldero G, De Lorenzo D, Volpetti S, Calimeri T, Perrone S, Cecchetti C, Ciceri F, Ponzoni M. LONG-TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT). Hematol Oncol 2019. [DOI: 10.1002/hon.65_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- A.J. Ferreri
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - M.C. Sassone
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - P. Angelillo
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - F. Zaja
- SC Ematologia; Azienda Sanitaria Universitaria Integrata; Trieste Italy
| | - A. Re
- Division of Hematology; Spedali Civili; Brescia Italy
| | - M. Spina
- Oncologia; Centro di Riferimento Oncologico; Aviano Italy
| | - A. Di Rocco
- Division of Hematology; University ”La Sapienza”; Rome Italy
| | - A. Fabbri
- Division of Hematology; Azienda Ospedaliera Università Senese; Siena Italy
| | - C. Stelitano
- Division of Hematology; Azienda Ospedaliera Bianchi-Melacrino-Morelli; Reggio Calabria Italy
| | - M. Frezzato
- Division of Hematology; San Bortolo Hospital; Vicenza Italy
| | - C. Rusconi
- Division of Hematology; Niguarda Hospital; Milan Italy
| | - R. Zambello
- Division of Hematology; Azienda Ospedaliera di Padua; Padua Italy
| | - A. Arcari
- Department of Oncology and Hematology; Guglielmo da Saliceto Hospital; Piacenza Italy
| | - G. Bertoldero
- U.O. di Oncologia ed Ematologia Oncologica; Ospedale di Mirano; Mirano Italy
| | - D. De Lorenzo
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - S. Volpetti
- Clinica Ematologia; Azienda Sanitaria Universitaria Integrata, DAME; Udine Italy
| | - T. Calimeri
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - S. Perrone
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - C. Cecchetti
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - F. Ciceri
- Onco-Hematology; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - M. Ponzoni
- Pathology; IRCCS San Raffaele Scientific Institute; Milan Italy
| |
Collapse
|
30
|
Visco C, Di Rocco A, Tisi M, Morello L, Evangelista A, Zilioli V, Rusconi C, Hohaus S, Sciarra R, Re A, Tecchio C, Chiappella A, Marin-Niebla A, McCulloch R, Gini G, Perrone T, Nassi L, Pennese E, Stefani P, Cox M, Bozzoli V, Fabbri A, Polli V, Ferrero S, De Celis I, Sica A, Arcaini L, Balzarotti M, Rule S, Vitolo U. OUTCOMES IN FIRST RELAPSED-REFRACTORY YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: RESULTS FROM THE MANTLE-FIRST STUDY. Hematol Oncol 2019. [DOI: 10.1002/hon.16_2629] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- C. Visco
- Medicine, Section of Hematology; University of Verona; Verona Italy
| | - A. Di Rocco
- Translational and Precision Medicine; Sapienza University of Rome; Rome Italy
| | - M.C. Tisi
- Medicine, Section of Hematology; University of Verona; Verona Italy
| | - L. Morello
- Hematology; Humanitas Clinical and Research Center; Rozzano Italy
| | - A. Evangelista
- Clinical Epidemiology; Città della Salute e della Scienza and CPO Piemonte; Torino Italy
| | - V.R. Zilioli
- Hematology; ASST Grande Ospedale Metropolitano Niguarda; Milano Italy
| | - C. Rusconi
- Hematology; ASST Grande Ospedale Metropolitano Niguarda; Milano Italy
| | - S. Hohaus
- Institute of Hematology, Policlinico Gemelli Foundation; Catholic University of the Sacred Heart; Roma Italy
| | - R. Sciarra
- Haematology Oncology; Fondazione IRCCS Policlinico San Matteo; Pavia Italy
| | - A. Re
- Hematology; Spedali Civili; Brescia Italy
| | - C. Tecchio
- Medicine, Section of Hematology and Bone Marrow Transplant; University of Verona; Verona Italy
| | - A. Chiappella
- Hematology; Città della salute e della scienza University Hospital; Torino Italy
| | - A. Marin-Niebla
- Hematology; Vall d'Hebron Institut d'Oncologia (VHIO); Barcelona Spain
| | - R. McCulloch
- Haematology; University of Plymouth and Derriford Hospital; Plymouth United Kingdom
| | - G. Gini
- Hematology, Department of Clinical and Molecular Sciences; Marche Polytechnic University; Ancona Italy
| | - T. Perrone
- Hematology; University of Bari; Bari Italy
| | - L. Nassi
- Hematology; Azienda Ospedaliero-Universitaria Maggiore della Carità; Novara Italy
| | - E. Pennese
- Hematology; UOSD "Centro Diagnosi e Terapia dei Linfomi"; PO Santo Spirito Pescara Italy
| | - P.M. Stefani
- Hematology; Ca' Foncello Hospital; Treviso Italy
| | - M.C. Cox
- Hematology; AOU Sant'Andrea; Rome Italy
| | | | - A. Fabbri
- Hematology; Azienda Ospedaliera Universitaria Senese & University of Siena; Siena Italy
| | - V. Polli
- Hematology; Ospedale degli Infermi; Rimini Italy
| | - S. Ferrero
- Molecular Biotechnologies and Health Sciences; University of Torino/AOU "Città della Salute e della Scienza di Torino"; Torino Italy
| | - I.A. De Celis
- Hematology; AUSLL/IRCCS Santa Maria Nuova Hospital; Reggio Emilia Italy
| | - A. Sica
- Hematology; Policlinico di Napoli; Napoli Italy
| | - L. Arcaini
- Haematology Oncology; Fondazione IRCCS Policlinico San Matteo; Pavia Italy
| | - M. Balzarotti
- Hematology; Humanitas Clinical and Research Center; Rozzano Italy
| | - S. Rule
- Haematology; University of Plymouth and Derriford Hospital; Plymouth United Kingdom
| | - U. Vitolo
- Hematology; Città della salute e della scienza University Hospital; Torino Italy
| |
Collapse
|
31
|
Stefoni V, Broccoli A, Botto B, Corradini P, Pinto A, Re A, Vitolo U, Fanti S, Argnani L, Zinzani P. FIRST SALVAGE TREATMENT WITH BENDAMUSTINE AND BRENTUXIMAB VEDOTIN IN HODGKIN LYMPHOMA: A PHASE 2 STUDY OF FIL ONLUS. Hematol Oncol 2019. [DOI: 10.1002/hon.105_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- V. Stefoni
- Institute of Hematology “L. e A. Seràgnoli”; University of Bologna; Bologna Italy
| | - A. Broccoli
- Institute of Hematology “L. e A. Seràgnoli”; University of Bologna; Bologna Italy
| | - B. Botto
- Hematology; Department of Oncology, University Hospital Città della Salute e della Scienza; Turin Italy
| | - P. Corradini
- IRCCS Istituto Nazionale dei Tumori; University of Milano; Milan Italy
| | - A. Pinto
- Hematology-Oncology and Stem Cell Transplantation Unit; National Cancer Institute, Fondazione Pascale; Naples Italy
| | - A. Re
- Hematology; Azienda socio-sanitaria territoriale, Ospedali Civili di Brescia; Brescia Italy
| | - U. Vitolo
- Hematology; Department of Oncology, University Hospital Città della Salute e della Scienza; Turin Italy
| | - S. Fanti
- Nuclear Medicine; Medicina Nucleare Metropolitana, Sant'Orsola-Malpighi Hospital, University of Bologna; Bologna Italy
| | - L. Argnani
- Institute of Hematology “L. e A. Seràgnoli”; University of Bologna; Bologna Italy
| | - P. Zinzani
- Institute of Hematology “L. e A. Seràgnoli”; University of Bologna; Bologna Italy
| |
Collapse
|
32
|
Re A, Chiloiro G, Boldrini L, Cellini F, Giraffa M, De Franco P, Corvari B, Meldolesi E, Fionda B, Cusumano D, Teodoli S, Valentini V, Gambacorta M. EP-1470 Response assessment in rectal cancer patients treated with MRI-guided RT: preliminary results. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31890-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
33
|
Dodero A, Guidetti A, Tucci A, Barretta F, Novo M, Devizzi L, Re A, Passi A, Pellegrinelli A, Pruneri G, Miceli R, Testi A, Pennisi M, Di Chio MC, Matteucci P, Carniti C, Facchetti F, Rossi G, Corradini P. Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma. Leukemia 2019; 33:1047-1051. [PMID: 30631117 PMCID: PMC6756077 DOI: 10.1038/s41375-018-0320-9] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2018] [Revised: 10/05/2018] [Accepted: 11/06/2018] [Indexed: 01/15/2023]
Affiliation(s)
- A Dodero
- Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | - A Guidetti
- Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. .,Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.
| | - A Tucci
- Department of Hematology, Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy
| | - F Barretta
- Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | - M Novo
- Department of Hematology, Azienda Ospedaliero Universitaria Citta' della Salute e della Scienza di Torino, Torino, Italy
| | - L Devizzi
- Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | - A Re
- Department of Hematology, Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy
| | - A Passi
- Department of Hematology, Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy
| | - A Pellegrinelli
- Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | - G Pruneri
- Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.,Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | - R Miceli
- Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | - A Testi
- Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | - M Pennisi
- Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | - M C Di Chio
- Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | - P Matteucci
- Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | - C Carniti
- Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | - F Facchetti
- Department of Pathology, Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy
| | - G Rossi
- Department of Hematology, Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy
| | - P Corradini
- Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.,Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy
| |
Collapse
|
34
|
Focà E, Cavaglià G, Rusconi S, Cascavilla A, Cenderello G, Re A, Casari S, van den Bogaart L, Zinzani PL, Caracciolo D, Di Perri G, Bonito A, Lucchini A, Cassola G, Viale P, Calcagno A. Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study. HIV Med 2018; 19:523-531. [PMID: 29862615 DOI: 10.1111/hiv.12624] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/15/2018] [Indexed: 11/29/2022]
Abstract
OBJECTIVES Lymphoproliferative disorders are often observed in HIV-positive patients. Combination antiretroviral treatment (cART) during antineoplastic chemotherapy is beneficial, but little is known about the clinical outcome according to different antiretroviral combinations. The aim of the study was to address this gap in current knowledge. METHODS A retrospective study was conducted in five large Italian centres for the period from 1998 to 2015; HIV-positive patients diagnosed with lymphoma were included and demographic, clinical and therapeutic variables were recorded and associated with clinical outcomes. Bivariate and multivariate analyses were performed, including Cox proportional hazard models for survival. RESULTS A total of 399 patients were included in the study. The most common types of lymphoma were diffuse large B-cell lymphoma (DLCLB; n = 164), Hodgkin lymphoma (HL; n = 99) and Burkitt lymphoma (BL; n = 57), followed by plasmablastic lymphoma (PBL; n = 38), T-cell lymphoma (TCL; n = 17), indolent lymphoma (n = 10) and other less common types (n = 14). cART was given to 327 (out of 387 evaluable) patients: in 216 subjects it was protease inhibitor (PI)-based, in 73 it was nonnucleoside reverse transcriptase inhibitor (NNRTI)-based and in 18 it was integrase strand transfer inhibitor (INSTI)-based (the remaining 20 individuals received other regimens). The 5-year overall survival was 57.5% (52.8% for DLCLB, 67.8% for HL, 42.3% for BL, 60.6% for PBL and 64.7% for TCL). PI-based ART compared with other compounds was associated with worse survival in non-Hodgkin lymphoma (NHL) and HL patients combined (P ≤ 0.001) and in NHL patients alone (P < 0.001); grade 3-4 haematological toxicities were more commonly observed in PI-treated individuals. Lymphoma diagnosis in recent years, better immunovirological status, lower lymphoma stage and better prognostic indexes were associated with better survival. CONCLUSIONS PI-based cART while on chemotherapy was associated with worse overall survival and more frequent haematological complications in HIV-positive patients with lymphoma.
Collapse
Affiliation(s)
- E Focà
- Department of Infectious and Tropical Diseases, University of Brescia and Brescia Spedali Civili Hospital, Brescia, Italy
| | - G Cavaglià
- Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy
| | - S Rusconi
- Department of Infectious Diseases, Ospedale Luigi Sacco, University of Milan, Milan, Italy
| | - A Cascavilla
- Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, S. Orsola-Malpighi Hospital, "Alma Mater Studiorum" University of Bologna, Bologna, Italy
| | - G Cenderello
- Department of Infectious Diseases, EO Ospedali Galliera, Genova, Italy
| | - A Re
- Unit of Haematology, Spedali Civili, Brescia, Italy
| | - S Casari
- Unit of Infectious Diseases, Carlo Poma Hospital, Mantova, Italy
| | - L van den Bogaart
- Department of Infectious Diseases, Ospedale Luigi Sacco, University of Milan, Milan, Italy
| | - P L Zinzani
- Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, S. Orsola-Malpighi Hospital, "Alma Mater Studiorum" University of Bologna, Bologna, Italy
| | - D Caracciolo
- Unit of Haematology, Department of Oncology, University of Torino, Torino, Italy
| | - G Di Perri
- Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy
| | - A Bonito
- Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy
| | - A Lucchini
- Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy
| | - G Cassola
- Department of Infectious Diseases, EO Ospedali Galliera, Genova, Italy
| | - P Viale
- Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, S. Orsola-Malpighi Hospital, "Alma Mater Studiorum" University of Bologna, Bologna, Italy
| | - A Calcagno
- Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy
| |
Collapse
|
35
|
Abstract
A research on the degree of knowledge about the problem of breast self-examination was carried out in a group of 500 women in the Out-patients Department of the Cancer Institute in Milan. The women were given a questionnaire to fill up at home and to return at the moment of the medical examination. The analysis of data showed that, though the level of education of the subjects was fairly good, the knowledge and the practise of the periodical self-examination as a method for an early diagnosis was very low. 70% of the women declared to have some knowledge about the method, but only 9% declared to practise it regularly.
Collapse
|
36
|
Tamburini M, Massara G, Bertario L, Re A, Di Pietro S. Usefulness of Breast Self-Examination for an Early Detection of Breast Cancer. Results of a Study on 500 Breast Cancer Patients and 652 Controls. Tumori 2018; 67:219-24. [PMID: 7281241 DOI: 10.1177/030089168106700310] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
The knowledge and practice of breast self-examination (BSE) was investigated among 500 women with operable breast tumors between 35 and 64 years of age (all successively operated) and 652 healthy women, matched with the previous group for 5-year age groups from 35 to 54 years. Only 39.9 % of breast cancer women and 34.5 % of the controls practiced BSE, and only a third of these did it monthly. Such practice tends to progressively decrease, starting from 45 years, and it is used less frequently by the women with a poor education and those in a lower economic bracket. Among the 500 breast cancer patients, those who practiced the self-examination had a higher number of tumors with a diameter no greater than 2 cm and a lower number with a diameter larger than 4 cm. In addition, in this group the percentage of unaffected axillary lymph nodes (N–) was 58.8 % compared to 48.8 % for the group that did not practice self-examination, and the percentage of the cases with more than 3 metastatic lymph nodes (N+ > 3) was 20.0 % in the first group and 27.3 % of the second one. These differences are statistically significant. The correlation between tumor diameter and the histologic lymph node stage is equally evident, since there is a progressive reduction in N– cases and a contemporary progressive increase in N+ (> 3) cases with increasing breast tumor diameter. Therefore, we can infer that the lack of practice of BSE causes a diagnostic and therapeutic delay, which is responsible for aggravation of the prognosis.
Collapse
|
37
|
Abstract
The chronology of first recurrences, their topographic distribution and survival from mastectomy were retrospectively studied in a series of 800 mastectomized women with special reference to the relationship between these data and treatment delay, T N categories and free interval. Visceral metastases were more frequent in patients under 50 years, whereas local recurrences were more common in patients over 50. The average free interval was 26 months (over 5 years in 18% of cases) and seemed to be influenced little by the treament delay or by tumor size; it was shorter in patients under 50 years and shorter still in patients with lymph node involvement at operation. A similar correlation exists between these parameters and survival. The 5 year survival rate of the 800 cases with recurrence was 52%, which is quite different from the rate generally indicated for surgical cases, and much higher than the rate for the natural history of untreated breast cancer. The survival rate in cases with first metastases confined to the soft tissues is much higher than in those with bone and/or with visceral metastases. The survival after recurrence proves to be significantly influenced by the length of the free interval, but much more by the presence or absence of regional lymph node involvement, so that the lymph nodes status (N–- or N+) turns out to be a prognostic item of primary importance, even after the onset of recurrence.
Collapse
|
38
|
Abstract
A case of postmastectomy lymphangiosarcoma of the arm, arising 13 years after the operation, is described. A singular character of the case was the absence of lymphedema in the affected arm.
Collapse
|
39
|
Abstract
A method of clinical investigation has been developed for the early diagnosis of mammary carcinoma based on the scoring of 10 Symptomatologie features of mammary nodules of doubtful malignancy. These features are: variations in size, consistency, form, surface, limits, mobility, protrusion, pain on pressure, presence and nature of secretion from the nipple, nature of axillary lymph nodes. Each feature is scored +2, + 1, 0, −1 or −2 according to whether it points to a malignant, doubtful or benign lesion, +2 and −2 indicating a more definite degree one way or the other. The number emerging from the algebric sum of the ten scores is rated as the complex score or clinical diagnostic index. The validity of the method was tested in 93 cases of clinically doubtful mammary nodules later subjected to histologic examination. The method yielded the right answer in 91 % (compared with 80 % for mammography) and false negatives in 2.2 % (compared with 15 %) of the 46 cases of mammary carcinoma. It yielded the right answer in 48.9 % (compared with 42.5 % for mammography) and 34 % false positives (same percentage as for mammography) of the 47 benign lesions. Thermography, used in about four-fifths of the cases, showed a much lower success rate. The combined outcome of clinical diagnostic index and mammography made it possible to avoid the preliminary classification of carcinomas as benign lesions. It was therefore concluded that the method is useful in uncertain mammary nodules, though the results of a larger trial, now in progress, must be awaited before expressing a definite verdict.
Collapse
|
40
|
Abstract
The results of a further trial of a clinical diagnostic index (CDI) for ill-defined mammary nodules, based on the algebrical results of positive numerical values (for a suspect feature), or negative numerical values (for non suspect feature), attributed to 10 characteristic semeiological features, previously described, are reported. 222 nodules were clinically examined, all subsequently subjected to mammography and 188 of them to ther-mograpy; they were then operated and examined histologically. Of 106 malignant nodules the accuracy of the CDI was 88.6 % with 4.7 % false negatives; for mammography 65 % with 21.7 % false negatives; for termography (out of 87 cases) 66.6 with 23 % false negatives. The accuracy in 116 benign nodules was 45.6 % for the CDI, 32.7 % for mammography and 29.7 % for termography (out of 101 cases). In three cases of malignant nodules in women below 35 years of age, all three examinations gave negative results. The relations between the diagnostic errors of the three examinations, as well as the dimensions and histo-type of the nodules are also considered. It may be concluded, that the CDI is a simple rapid and highly accurate clinical investigation for early diagnosis of mammary carcinoma.
Collapse
|
41
|
Gambacorta M, Chiloiro G, Re A. SP-0344: Against the motion. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)30654-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
42
|
Porcelli A, Agostini M, Altenmüller K, Appel S, Atroshchenko V, Bagdasarian Z, Basilico D, Bellini G, Benziger J, Bick D, Bonfini G, Bravo D, Caccianiga B, Calaprice F, Caminata A, Caprioli S, Carlini M, Cavalcante P, Chepurnov A, Choi K, Cloué O, Cribier M, D'Angelo D, Davini S, Derbin A, Ding X, Di Ludovico A, Di Noto L, Drachnev I, Durero M, Farinon S, Fischer V, Fomenko K, Formozov A, Franco D, Froborg F, Gabriele F, Gaffiot J, Galbiati C, Ghiano C, Giammarchi M, Goretti A, Gromov M, Gschwender M, Hagner C, Houdy T, Hungerford E, Ianni A, Ianni A, Jonquères N, Jany A, Jeschke D, Kobychev V, Korablev D, Korga G, Kornoukhov V, Kryn D, Lachenmaier T, Lasserre T, Laubenstein M, Litvinovich E, Lombardi F, Lombardi P, Ludhova L, Lukyanchenko G, Lukyanchenko L, Machulin I, Manuzio G, Marcocci S, Maricic J, Mention G, Martyn J, Meroni E, Meyer M, Miramonti L, Misiaszek M, Muratova V, Musenich R, Neumair B, Oberauer L, Opitz B, Ortica F, Pallavicini M, Papp L, Pilipenko N, Pocar A, Ranucci G, Razeto A, Re A, Romani A, Roncin R, Rossi N, Rottenanger S, Schönert S, Scola M, Semenov D, Skorokhvatov M, Smirnov O, Sotnikov A, Stokes L, Suvorov Y, Tartaglia R, Testera G, Thurn J, Toropova M, Unzhakov E, Veyssiére C, Vishneva A, Vivier M, Vogelaar R, von Feilitzsch F, Wang H, Weinz S, Wojcik M, Wurm M, Yokley Z, Zaimidoroga O, Zavatarelli S, Zuber K, Zuzel G. Recent Borexino results and perspectives of the SOX measurement. EPJ Web Conf 2018. [DOI: 10.1051/epjconf/201818202099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Borexino is a liquid scintillator detector sited underground in the Laboratori Nazionali del Gran Sasso (Italy). Its physics program, until the end of this year, is focussed on the study of solar neutrinos, in particular from the Beryllium, pp, pep and CNO fusion reactions. Knowing the reaction chains in the sun provides insights towards physics disciplines such as astrophysics (star physics, star formation, etc.), astroparticle and particle physics. Phase II started in 2011 and its aim is to improve the phase I results, in particular the measurements of the neutrino fluxes from the pep and CNO processes. By the end of this year, data taking from the sun will be over and a new project is scheduled to launch: Short distance Oscillation with boreXino (SOX), which uses a Cerium source for neutrinos (100÷150 kCi of activity) and aims to confirm or rule out the presence of sterile neutrinos. This particle is hypothesised to justify the reactor, Gallium and LSND anomalies found and can reject extensions to the standard model. The work presented is a summary of the solar neutrino results achieved so far, which lead not only to a precise study of the processes in the sun, but also to more Standard Model oriented measurements (such as the stability of the charge, i.e. the life time of the electron). Furthermore, the perspectives of the SOX program are discussed showing the experiment sensitivity to a fourth neutrino state covering almost entirely 3σ of the preferred region of the anomalous neutrino experiments, and additional applications of the detector such as the study of geo-neutrinos.
Collapse
|
43
|
Iannone L, Vignale M, Pinget A, Re A, Mc Cargo P, Novas M. Seed-transmitted Epichloë sp. endophyte alleviates the negative effects of head smut of grasses (Ustilago bullata) on Bromus auleticus. FUNGAL ECOL 2017. [DOI: 10.1016/j.funeco.2017.06.001] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
44
|
Sassone M, Zaja F, Re A, Spina M, Di Rocco A, Fabbri A, Stelitano C, Frezzato M, Rusconi C, Zambello R, Calimeri T, Scarfò L, Cecchetti C, Chiozzotto M, Ponzoni M, Ferreri A. A multicentre phase II trial addressing lenalidomide (LEN) maintenance in patients with relapsed diffuse large b-cell lymphoma (rDLBCL) who are not eligible for autologous stem cell transplantation (ASCT). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx373.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
45
|
Roselli G, Re A, Carbonara F, Bruno G. Validità estetica e funzionale dei restauri coronali parziali in composito: caso clinico. Dental Cadmos 2017. [DOI: 10.19256/d.cadmos.06.2017.08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
46
|
Chiappella A, Carniti C, Ceccarelli M, Cabras M, Re A, Salvi F, Santoro A, Stefoni V, Pileri S, Ciccone G, Corradini P. FIL-PTCL13: PHASE IB/II STUDY OF ROMIDEPSIN/CHOEP FOLLOWED BY HIGH-DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T-CELL LYMPHOMAS. Hematol Oncol 2017. [DOI: 10.1002/hon.2440_10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- A. Chiappella
- Hematology; AOU Città della Salute e della Scienza, On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - C. Carniti
- Division of Hematology and Bone Marrow Transplant, Fondazione IRCCS Istituto Nazionale dei Tumori; Department of Oncology and Hemato-Oncology; University of Milan, On behalf of Fondazione Italiana Linfomi (FIL); Milan Italy
| | - M. Ceccarelli
- Unit of Clinical Epidemiology, CPO; AOU Città della Salute e della Scienza di Torino, On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - M.G. Cabras
- Hematology, Ospedale “A. Businco” Cagliari; Haematology & Transplant Centre “Wilma Deplano”, On behalf of Fondazione Italiana Linfomi (FIL); Cagliari Italy
| | - A. Re
- Hematology, Azienda Ospedaliera Spedali Civili di Brescia; On behalf of Fondazione Italiana Linfomi (FIL); Brescia Italy
| | - F. Salvi
- Hematology, Azienda Ospedaliera Nazionale SS.Antonio e Biagio e C. Arrigo; On behalf of Fondazione Italiana Linfomi (FIL); Alessandria Italy
| | - A. Santoro
- Hematology, Istituto Clinico Humanitas and IRCCS; On behalf of Fondazione Italiana Linfomi (FIL); Rozzano Italy
| | - V. Stefoni
- Hematology, Istituto L e A Seragnoli, Policlinico S. Orsola-Malpighi; On behalf of Fondazione Italiana Linfomi (FIL); Bologna Italy
| | - S. Pileri
- Institute of Hematology "L. e A. Seràgnoli", Universita degli Studi di Bologna and Haematopathology Unit; Istituto Europeo di Oncologia, On behalf of Fondazione Italiana Linfomi (FIL); Milan Italy
| | - G. Ciccone
- Unit of Clinical Epidemiology, CPO; AOU Città della Salute e della Scienza di Torino, On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - P. Corradini
- Division of Hematology and Bone Marrow Transplant, Fondazione IRCCS Istituto Nazionale dei Tumori; Department of Oncology and Hemato-Oncology; University of Milan, On behalf of Fondazione Italiana Linfomi (FIL); Milan Italy
| |
Collapse
|
47
|
Schieppati F, Balzarini P, Fisogni S, Re A, Peli A, Passi A, Roccaro A, Lorenzi L, Cattaneo C, Facchetti F, Rossi G, Tucci A. Unfavorable prognostic impact of MYC
increased copy number (ICN) in patients with diffuse large B-cell (DLBCL) and high-grade lymphoma treated with immunochemotherapy. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- F. Schieppati
- Hematology; ASST Spedali Civili di Brescia; Brescia Italy
| | - P. Balzarini
- Pathology; ASST Spedali Civili di Brescia; Brescia Italy
| | - S. Fisogni
- Pathology; ASST Spedali Civili di Brescia; Brescia Italy
| | - A. Re
- Hematology; ASST Spedali Civili di Brescia; Brescia Italy
| | - A. Peli
- Hematology; ASST Spedali Civili di Brescia; Brescia Italy
| | - A. Passi
- Hematology; ASST Spedali Civili di Brescia; Brescia Italy
| | - A. Roccaro
- Hematology; ASST Spedali Civili di Brescia; Brescia Italy
| | - L. Lorenzi
- Pathology; ASST Spedali Civili di Brescia; Brescia Italy
| | - C. Cattaneo
- Hematology; ASST Spedali Civili di Brescia; Brescia Italy
| | - F. Facchetti
- Pathology; ASST Spedali Civili di Brescia; Brescia Italy
| | - G. Rossi
- Hematology; ASST Spedali Civili di Brescia; Brescia Italy
| | - A. Tucci
- Hematology; ASST Spedali Civili di Brescia; Brescia Italy
| |
Collapse
|
48
|
Re A, Chiloiro G, Gambacorta M, Cellini F, Pesce A, Marchesano D, Mattiucci G, Manfrida S, Valentini V. EP-1281: Feasibility and Toxicity analysis of doseescalation by SIB/VMAT schedule in rectal cancer patients. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31716-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
49
|
Chiesa S, Menna S, Alitto A, Azario L, Mattiucci G, Ferro M, Massaccesi M, Re A, Piermattei A, Valentini V, Balducci M. EP-1651: Dosimetric impact of rotations correction in Stereotactic RT. How much a 6DoF couch is useful? Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)32086-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
50
|
Gambacorta M, Chiloiro G, Masciocchi C, Dinapoli N, Cellini F, Re A, Valentini V. SP-0204: Decision support systems and shared decision making. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30647-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|